CoChat

Herbal medicine for depression and anxiety:Asystematic review with assessment of potential psycho‐oncologic relevance

Open access
Yeung, K. Simon, Hernandez, Marisol, Mao, Jun J., Haviland, Ingrid, Gubili, Jyothirmai · 2018 · Phytotherapy Research
Cited by 229

The DOI matches its Crossref record; 138 of the 138 references it cites were found in a registry or an index.

Abstract

Anxiety and depression are prevalent among cancer patients, with significant negative impact. Many patients prefer herbs for symptom relief to conventional medications which have limited efficacy/side effects. We identified single‐herb medicines that may warrant further study in cancer patients. Our search included PubMed, Allied and Complementary Medicine, Embase, and Cochrane databases, selecting only single‐herb randomized controlled trials between 1996 and 2016 in any population for data extraction, excluding herbs with known potential for interactions with cancer treatments. One hundred articles involving 38 botanicals met our criteria. Among herbs most studied (≥6 randomized controlled trials each), lavender, passionflower, and saffron produced benefits comparable to standard anxiolytics and antidepressants. Black cohosh, chamomile, and chasteberry are also promising. Anxiety or depressive symptoms were measured in all studies, but not always as primary endpoints. Overall, 45% of studies reported positive findings with fewer adverse effects compared with conventional medications. Based on available data, black cohosh, chamomile, chasteberry, lavender, passionflower, and saffron appear useful in mitigating anxiety or depression with favorable risk–benefit profiles compared to standard treatments. These may benefit cancer patients by minimizing medication load and accompanying side effects. However, well‐designed larger clinical trials are needed before these herbs can be recommended and to further assess their psycho‐oncologic relevance.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ptr.6033

Cites

138 of 138 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 13

  1. Cieza A., 2003, The effect of ginkgo biloba on healthy elderly subjects, Fortschritte der Medizin. Originalien, 121, 5
  2. De Leo V., 2000, Assessment of the association of kava‐kava extract and hormone replacement therapy in the treatment of postmenopause anxiety, Minerva Ginecologica, 52, 263
  3. 10.1515/jpem-2015-0248 · doi:10.1515/jpem-2015-0248
  4. Dorn M., 2000, Efficacy and tolerability of Baldrian versus oxazepam in non‐organic and non‐psychiatric insomniacs: A randomised, double‐blind, clinical, comparative study, Forschende Komplementärmedizin und Klassische Naturheilkunde, 7, 79
  5. Genazzani A. D., 2010, Effects of Klamath Algae extract on psychological disorders and depression in menopausal women: A pilot study [Italian], Minerva Ginecologica, 62, 381
  6. 10.1055/s-0029-1186153 · doi:10.1055/s-0029-1186153
  7. 10.5414/CPP45143 · doi:10.5414/cpp45143
  8. 10.1097/01.gme.0000251932.48426.35 · DOI
  9. Kumar T., 2011, Randomized control, double blind cross‐over study to clinically assess the rasayana effect of a standardized extract of Brahmi (Bacopa monniera) in adult human volunteers, International Journal of Pharmacy and Pharmaceutical Sciences, 3, 263
  10. Litvinenko I. V., 2014, Treatment of cognitive and non‐cognitive symptoms in cerebrovascular disease, Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova, 114, 35
  11. 10.1007/s13318-016-0351-4 · doi:10.1007/s13318-016-0351-4
  12. Zamani M., 2012, Therapeutic effect of Vitex agnus Castus in patients with premenstrual syndrome, Acta Medica Iranica, 50, 101
  13. Zheng T. P., 2013, Efficacy and safety of Cimicifuga foetida extract on menopausal syndrome in Chinese Women, Chinese Medical Journal, 126, 2034, 10.3760/cma.j.issn.0366-6999.20122602 · doi:10.3760/cma.j.issn.0366-6999.20122602

Cited by

See all 229

Metadata

Authors
Yeung, K. S., Hernandez, M., Mao, J. J., Haviland, I., & Gubili, J.
Venue
Phytotherapy Research
Publisher
Wiley
Published
2018-02-21
Volume
32
Issue
5
Pages
865-891
ISSN
  • 0951-418X (ISSN-L)
  • 1099-1573
OpenAlex
W2791314673
Cited by
229
References
138
FWCI
6.00
Type
journal article
Language
en
Open access
green
Funders
NIH/NCI Cancer Center Support Grant (P30 CA008748)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.